A 6-year experience treating vascular malformations with foam sclerotherapy

Jovan N Markovic1, Charles Y Kim, Michael E Lidsky

  • 1Duke University School of Medicine, Durham, NC, USA. jovan.markovic@duke.edu

Summary

Sodium tetradecyl sulfate foam sclerotherapy (STS FS) effectively treats most low-flow vascular malformations. Microcystic malformations, however, require surgical resection for optimal outcomes.